Epidemiological and socio-economic support patients living with epilepsy in dakar, senega

##plugins.themes.academic_pro.article.sidebar##

Published Jun 25, 2015
Download
pdf
Vol. 93 No. 2 (2015): Issue Feb 2015

##plugins.themes.academic_pro.article.main##

Fall Maouly
Touré Kamadore
Seck Lala Bouna
Ndiaye Moustapha
Diop Amadou Gallo
Ndiaye Mouhamadou Mansour

Abstract

Background: Epilepsy remains a major public health problem especially in developing countries where access to new therapies remains limited. Objective: The aim of this work was to study the socio-demographic profile of patients living with epilepsy in Dakar and supported.
Methods: We conducted a cross-sectional study over a period of eight months from November 2009 to June 2010 at Fann University Hospital and Health Center Pikine through research on adherence.
Results: The study involved patients living with epilepsy aged over 15 years, diagnosed clinically with epilepsy and/or confirmed by an electroencephalogram and put under antiepileptic drug for more than 3 months. We recruited 411 patients aged 15-74 years with a mean age of 28.93 years. The age range was 15-24 years with 44.6 % majority. The male sex predominated with 52.3 % and the sex ratio was 1.09. Singles outnumbered with 64.7 %. The level of education was the most representative secondary with 29.4 % and patients without profession were 35.5 %. Most of the patients was from semi-urban areas with 47.7 %. Generalized seizures were more frequent with about 70 %. Most of the patients was supported either by their family or by themselves.
Conclusion: The management should be multisectoral for epilepsy out of darkness.

Keywords:

Epidemiology-Management-Epilepsy

##plugins.themes.academic_pro.article.details##

References

  1. Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr. Epileptic seizures and epilepsy. Definitions proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005; 46: 470- 472
  2. Diop AG et al. Developed versus undeveloped conditions in the management of epilepsy: advantages and disadvantages. Epilepsia, 2001; 42(3): 439-440.
  3. Diop AG et al. The treatment gap. In: Epilepsy care in the world Atlas. WHO Geneva. 2005a: 42-45
  4. Diop AG, De Boer HM, Mandlhate C, Prilipko L, Meinardi H. The global campaign against epilepsy in Africa. Acta Trop 2003; 87:149-159.
  5. Diop AG, Hesdorffer DC, Logroscino G, Hauser WA. Epilepsy and mortality in Africa: a review of the literature Epilepsia 2005 b; 46(1): 33-35
  6. Diop AG, Ndiaye M, Diagne M, Thiam A, Diouf FS. Filières des soins anti- épileptiques en Afrique. Epilepsies 1998; 10 :115-121
  7. Sabaté E et al. Adherence to Long term Therapies: Evidence for Action. World Health Organization. Geneva, 2003: 212 pp.
  8. Mbuba CK, Ngugi AK, Newton CR, Carter JA. The epilepsy treatment gap in developing countries: A systematic review of the magnitude, causes, and intervention strategies. Epilepsia, 2008; 49(9): 1491-1503
  9. Meinardi H, Scott RA, Reis R, Sander JW. Commission on the Developing World. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 2001; 42: 136-149
  10. Thomas SV and al. Epilepsy care in six Indian cities: a multicenter study on management and service: Journal of the Neurological Sciences 188 (2001) 73-77
  11. Deetha S et al. Women with onset of Epilepsy prior to marriage: disclose or conceal? Epilepsia, 2007; 48 (5): 1007-1010
  12. Nimaga K, Desplats D, Doumbo O, Farnarier G. Treatment with phenobarbital and monitoring of epileptic patients in rural Mali. Bull World Health Org 2002; 80: 532-537
  13. Cramer J, Vachon L, Desforge C, et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995; 36: 1111-1117.